Colin I M, Jameson J L
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Endocrinology. 1998 Sep;139(9):3796-802. doi: 10.1210/endo.139.9.6198.
During the female reproductive cycle, estrogen enhances the actions of GnRH on the gonadotrope cell. Recently, we reported that in vivo exposure to estradiol causes a marked enhancement GnRH-induced transcription of the alpha gene promoter in primary cultures of pituitary cells. In the present study, we analyzed the GnRH signaling pathways that mediate the sensitizing effects of estradiol on the alpha promoter. Primary cultures of male and female rat pituitary cells were transfected with the -420alphaLUC reporter gene and treated with agonists or antagonists for 24 h. As found previously, the degree of GnRH (1 nM) stimulation was 15-fold greater in females (157-fold) than in males (9-fold). When cells were treated with phorbol esters [phorbol 12-myristate 13-acetate (PMA); 10 nM], the level of stimulation was half that observed with GnRH, but the sexual dimorphism was preserved. When protein kinase C (PKC) activity was either depleted by long term treatment with phorbol esters (1 microM PMA for 24 h) or inhibited with staurosporine, the stimulatory effect of GnRH was minimally affected in males, but was markedly reduced in females. The reduced threshold of GnRH responsiveness after inhibition of PKC suggests that the actions of estrogen involve this pathway. Coexpression of c-jun and c-fos, which are increased by GnRH and PMA, suppressed basal alphaLUC activity, but did not alter the sensitivity to GnRH in a sexually dimorphic manner. Dominant negative mutants of the mitogen-activated protein kinase pathway, which is also activated by GnRH and PMA, failed to reveal sexually dimorphic alterations in GnRH responsiveness. These findings indicate that the mitogen-activated protein kinase pathway and activating protein-1 are probably not involved in estrogen sensitization of transcriptional responses to GnRH. The involvement of Ca2+-dependent pathways was analyzed either by chelating extracellular Ca2+ with EGTA (5 mM) or by using a Ca2+ channel blocker, methoxyverapamil (D600; 1 microM). Depletion of extracellular Ca2+ markedly reduced GnRH action in females, but not in males. Treatment with the Ca2+ channel blocker D600 did not alter GnRH-induced stimulation of -420alphaLUC in males, but in females, GnRH stimulation was significantly impaired (208- vs. 23-fold). Estrogen replacement in ovariectomized females reconstituted GnRH sensitivity and the inhibitory effect of methoxyverapamil (84- vs. 13-fold). We conclude that both PKC- and Ca2+-dependent signaling pathways are involved in estradiol-induced sensitization of female pituitary cells to GnRH.
在雌性生殖周期中,雌激素可增强促性腺激素释放激素(GnRH)对促性腺激素细胞的作用。最近,我们报道了体内暴露于雌二醇会导致垂体细胞原代培养物中GnRH诱导的α基因启动子转录显著增强。在本研究中,我们分析了介导雌二醇对α启动子致敏作用的GnRH信号通路。用-420αLUC报告基因转染雄性和雌性大鼠垂体细胞原代培养物,并用激动剂或拮抗剂处理24小时。如先前发现的那样,GnRH(1 nM)刺激程度在雌性(157倍)中比在雄性(9倍)中高15倍。当用佛波酯[佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA);10 nM]处理细胞时,刺激水平是GnRH处理时观察到的一半,但性别差异得以保留。当蛋白激酶C(PKC)活性通过长期用佛波酯(1 μM PMA处理24小时)耗尽或用星形孢菌素抑制时,GnRH的刺激作用在雄性中受影响最小,但在雌性中显著降低。PKC抑制后GnRH反应性阈值降低表明雌激素的作用涉及该途径。GnRH和PMA可增加c-jun和c-fos的共表达,其抑制了基础αLUC活性,但未以性别差异的方式改变对GnRH的敏感性。丝裂原活化蛋白激酶途径的显性负性突变体,其也由GnRH和PMA激活,未能揭示GnRH反应性的性别差异改变。这些发现表明丝裂原活化蛋白激酶途径和活化蛋白-1可能不参与雌激素对GnRH转录反应的致敏作用。通过用乙二醇双四乙酸(EGTA,5 mM)螯合细胞外Ca2+或使用Ca2+通道阻滞剂甲氧基维拉帕米(D600;1 μM)分析Ca2+依赖性途径的参与情况。细胞外Ca2+的耗尽显著降低了GnRH在雌性中的作用,但在雄性中未降低。用Ca2+通道阻滞剂D600处理未改变GnRH诱导的雄性-420αLUC刺激,但在雌性中,GnRH刺激显著受损(208倍对23倍)。去卵巢雌性中的雌激素替代恢复了GnRH敏感性以及甲氧基维拉帕米的抑制作用(84倍对13倍)。我们得出结论,PKC依赖性和Ca2+依赖性信号通路均参与雌二醇诱导的雌性垂体细胞对GnRH的致敏作用。